SE8501312D0 - ETOPOSIDE ORAL DOSAGE FORM - Google Patents

ETOPOSIDE ORAL DOSAGE FORM

Info

Publication number
SE8501312D0
SE8501312D0 SE8501312A SE8501312A SE8501312D0 SE 8501312 D0 SE8501312 D0 SE 8501312D0 SE 8501312 A SE8501312 A SE 8501312A SE 8501312 A SE8501312 A SE 8501312A SE 8501312 D0 SE8501312 D0 SE 8501312D0
Authority
SE
Sweden
Prior art keywords
dosage form
etoposide
oral dosage
etoposide oral
acid
Prior art date
Application number
SE8501312A
Other languages
Swedish (sv)
Other versions
SE8501312L (en
Inventor
S Begum
I Ullah
B C Nunning
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8501312D0 publication Critical patent/SE8501312D0/en
Publication of SE8501312L publication Critical patent/SE8501312L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

A liquid dosage form suitable for oral administration of etoposide which is sufficiently concentrated to be administered in capsule form and which provides improved absorption of the drug relative to prior oral formulations, comprises etoposide, polyethylene glycol, taurocholic acid, ethanol and a water-soluble acid.
SE8501312A 1984-03-19 1985-03-18 ORAL DOSAGE FORM FOR ETOPSIDE SE8501312L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59114484A 1984-03-19 1984-03-19

Publications (2)

Publication Number Publication Date
SE8501312D0 true SE8501312D0 (en) 1985-03-18
SE8501312L SE8501312L (en) 1985-09-20

Family

ID=24365235

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8501312A SE8501312L (en) 1984-03-19 1985-03-18 ORAL DOSAGE FORM FOR ETOPSIDE

Country Status (28)

Country Link
JP (1) JPS60209516A (en)
KR (1) KR850006136A (en)
AT (1) AT392904B (en)
AU (1) AU571308B2 (en)
BE (1) BE901963A (en)
CA (1) CA1238578A (en)
CH (1) CH662731A5 (en)
DE (1) DE3509741A1 (en)
DK (1) DK164535C (en)
EG (1) EG17521A (en)
ES (1) ES8702140A1 (en)
FI (1) FI84023C (en)
FR (1) FR2561104B1 (en)
GB (1) GB2155789B (en)
GR (1) GR850688B (en)
IE (1) IE58340B1 (en)
IL (1) IL74615A (en)
IT (1) IT1187640B (en)
LU (1) LU85812A1 (en)
MY (1) MY101916A (en)
NL (1) NL8500739A (en)
NO (1) NO170569C (en)
NZ (1) NZ211078A (en)
OA (1) OA07968A (en)
PT (1) PT80131B (en)
SE (1) SE8501312L (en)
YU (1) YU45243B (en)
ZA (1) ZA851935B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60239418A (en) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd Soft capsule containing etoposide
JPS61189230A (en) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd Etoposide preparation
DE3629386A1 (en) * 1986-08-29 1988-03-03 Scherer Gmbh R P GELATINE CAPSULES AND METHOD FOR THEIR PRODUCTION
US4927638A (en) * 1986-10-08 1990-05-22 Bristol-Myers Company Etoposide solutions
US5154930A (en) * 1987-03-05 1992-10-13 The Liposome Company, Inc. Pharmacological agent-lipid solution preparation
US5376381A (en) * 1988-02-25 1994-12-27 The Liposome Company, Inc. Integrity protected gelatin
JP2000247911A (en) * 1999-02-26 2000-09-12 Hisamitsu Pharmaceut Co Inc Absorption promoter for large intestine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH580255A5 (en) * 1974-06-04 1976-09-30 Calinter Sa
DE2452785A1 (en) * 1974-11-07 1976-05-13 Universal Oil Prod Co Engine crankcase gases treatment - by catalytic reactor in heat exchange and partial mixture with exhaust gases
FR2358144A1 (en) * 1976-07-13 1978-02-10 Lipha Compsn. for treating biliary lithiasis - contains hymecromone and chenodeoxy-cholic acid, with lower cost and better tolerance
JPS5940137B2 (en) * 1976-10-14 1984-09-28 武田薬品工業株式会社 Pharmaceutical composition for oral administration
FR2410504A1 (en) * 1977-12-05 1979-06-29 Air Liquide Safety control in chemical reactor carrying out oxidations - comprises oxygen concn. monitoring in gaseous phase and nitrogen injections if set concn. is reached
DE2809543A1 (en) * 1978-03-06 1979-09-13 Werner Henke Rendering oil or gas well gases harmless - by desulphurisation and oxidn. in catalytic reactors
JPS60239418A (en) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd Soft capsule containing etoposide

Also Published As

Publication number Publication date
NO851022L (en) 1985-09-20
AU3897585A (en) 1985-09-26
AT392904B (en) 1991-07-10
FI84023C (en) 1991-10-10
NO170569B (en) 1992-07-27
DK122285A (en) 1985-09-20
FI851040A0 (en) 1985-03-15
PT80131B (en) 1987-10-20
ZA851935B (en) 1985-10-30
SE8501312L (en) 1985-09-20
FI84023B (en) 1991-06-28
NL8500739A (en) 1985-10-16
ATA81985A (en) 1990-12-15
AU571308B2 (en) 1988-04-14
YU45243B (en) 1992-05-28
IE850686L (en) 1985-09-19
DK164535B (en) 1992-07-13
GB2155789A (en) 1985-10-02
IT8519897A0 (en) 1985-03-14
FR2561104B1 (en) 1988-04-08
ES541370A0 (en) 1986-12-16
KR850006136A (en) 1985-10-02
JPS60209516A (en) 1985-10-22
EG17521A (en) 1990-06-30
IT1187640B (en) 1987-12-23
DK122285D0 (en) 1985-03-18
CA1238578A (en) 1988-06-28
NO170569C (en) 1992-11-04
PT80131A (en) 1985-04-01
IL74615A (en) 1988-07-31
GR850688B (en) 1985-07-08
DE3509741A1 (en) 1985-09-26
IE58340B1 (en) 1993-09-08
GB2155789B (en) 1987-10-21
FI851040L (en) 1985-09-20
YU42085A (en) 1988-02-29
ES8702140A1 (en) 1986-12-16
OA07968A (en) 1987-01-31
BE901963A (en) 1985-09-18
DK164535C (en) 1992-11-30
CH662731A5 (en) 1987-10-30
IL74615A0 (en) 1985-06-30
GB8506943D0 (en) 1985-04-24
MY101916A (en) 1992-02-15
NZ211078A (en) 1987-08-31
LU85812A1 (en) 1985-12-12
FR2561104A1 (en) 1985-09-20

Similar Documents

Publication Publication Date Title
ES2040232T3 (en) MEDICINAL PREPARATIONS FOR ORAL ADMINISTRATION CONTAINING A SINGLE DOSE OF 10 TO 240 MG OF DIHIDROPIRIDINA.
DE3679722D1 (en) SPRAYABLE PHARMACEUTICAL PREPARATION FOR TOPICAL APPLICATION.
MX171191B (en) PHARMACEUTICAL COMPOSITIONS OF GLIPIZIDE
NO177177C (en) Process for the preparation of a liquid dosage form for oral administration of a pharmaceutical substance
IT1270594B (en) CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION OF LIQUID SUSPENSION MOGUISTEIN
NO953189L (en) Aqueous drug preparation with the ability of reversible thermosetting gelling
IS1564B (en) Process for the preparation of N1-substituted benzimidazole derivatives for therapeutic use
DE69421918T2 (en) HIGH DOSE MEDICINAL COMPOSITIONS
DE58906926D1 (en) New drug formulation and process for its manufacture.
SE8402551L (en) CINNAMOYLMORANOLIN DERIVATIVES
NO177376C (en) Process for the preparation of a pharmaceutical dosage form based on a tampon printing method
EP0177342A3 (en) Oral formulation of therapeutic proteins
SE8501312D0 (en) ETOPOSIDE ORAL DOSAGE FORM
DE69004532T2 (en) Medicinal preparations containing topical defibrotide.
DE3764111D1 (en) COMBINATION OF MEDICINAL PRODUCTS.
IT1151953B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AFFECTIONS OF THE ORAL CAVITY
NO810480L (en) ANOLOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,3,4-OCSADIAZOLYLPHENOL DERIVATIVES
DK0450123T3 (en) Pharmaceutical preparation for topical administration containing dichlofenac sodium
DE3689254D1 (en) Dextrorphan-based drugs for intranasal application.
SE8705035L (en) APPLICATION OF ALKYLGYLERICEROL
ATE4808T1 (en) PIPERIDINE DERIVATIVES OF 3-HYDROXY-THIOPHEN-2CARBONS[UREESTERS, THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
NO155620C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DIBENZO (A, D) -CYCLOHEPTEN DERIVATIVES.
IT1166217B (en) PHARMACEUTICAL COMPOSITION FOR MALE STERILITY THERAPY
HK44184A (en) Pharmaceutical preparation for administration to the mucosa of the oral or nasal cavity

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8501312-6

Effective date: 19931230

Format of ref document f/p: F